Results 21 to 30 of about 125,699 (320)

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential

open access: yesExpert Review of Anti-Infective Therapy, 2023
Introduction Tecovirimat oral capsule formulation is approved in the US and Canada for treatment of smallpox and in the United Kingdom (UK) and European Union (EU) for treatment of multiple human orthopoxvirus diseases, including mpox.
Andrew T. Russo   +4 more
semanticscholar   +1 more source

PREVALENCE OF SMALLPOX [PDF]

open access: greenAmerican Journal of Public Health, 1925
DURING THE past few years, health officers have warned the public of the increasing prevalence of smallpox throughout the United States and Canada. The report of the Surgeon General, U. S. Public Health Service, for 1924 stated that smallpox was the most widely distributed plague in the world, and that approximately one-fifth of all the cases of ...
C. C. Pierce
openalex   +4 more sources

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model

open access: yesMsphere, 2021
Preparedness activities against highly transmissible viruses with high mortality rates have been highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic.
C. Hutson   +14 more
semanticscholar   +1 more source

Neurologic Complications of Smallpox and Monkeypox: A Review.

open access: yesJAMA Neurology, 2022
Importance Orthopox viruses include smallpox virus, a once feared but now eradicated virus, as well as monkeypox virus. Monkeypox is an emerging virus initially isolated in 1958, previously unrecognized outside sub-Saharan Africa until a worldwide ...
B. Billioux   +3 more
semanticscholar   +1 more source

The rediscovery of smallpox [PDF]

open access: yesClinical Microbiology and Infection, 2014
Smallpox is an infectious disease that is unique to humans, caused by a poxvirus. It is one of the most lethal of diseases; the virus variant Variola major has a mortality rate of 30%. People surviving this disease have life-long consequences, but also assured immunity. Historically, smallpox was recognized early in human populations.
Thèves, Catherine   +2 more
openaire   +3 more sources

History of Smallpox

open access: yesJournal of Nepal Medical Association, 2003
NA
P N Shrestha
doaj   +1 more source

Acute Late-Stage Myocarditis in the Crab-Eating Macaque Model of Hemorrhagic Smallpox

open access: yesViruses, 2021
Hemorrhagic smallpox, caused by variola virus (VARV), was a rare but nearly 100% lethal human disease manifestation. Hemorrhagic smallpox is frequently characterized by secondary bacterial infection, coagulopathy, and myocardial and subendocardial ...
Reed F. Johnson   +19 more
doaj   +1 more source

Smallpox in Providence [PDF]

open access: greenThe Boston Medical and Surgical Journal
n ...
Edwin M. Snow
openalex   +5 more sources

An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

open access: yesExpert Review of Anti-Infective Therapy, 2020
Introduction Tecovirimat (TPOXX®; ST-246) was approved for the treatment of symptomatic smallpox by the USFDA in July of 2018 and has been stockpiled by the US government for use in a smallpox outbreak.
Andrew T. Russo   +8 more
semanticscholar   +1 more source

Progression of pathogenic events in cynomolgus macaques infected with variola virus. [PDF]

open access: yesPLoS ONE, 2011
Smallpox, caused by variola virus (VARV), is a devastating human disease that affected millions worldwide until the virus was eradicated in the 1970 s.
Victoria Wahl-Jensen   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy